Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-22

Clinical Trial Update: B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV [NA]

View source ↗

Summary

A clinical trial is evaluating B. Infantis probiotic supplementation to boost immunity in infants exposed to HIV. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • B. Infantis probiotic (Bifidobacterium longum subsp. infantis)

Snippet

Sponsor: University of Cape Town | Conditions: Hiv, Vaccine Reaction | NA | Status: RECRUITING